Skip to main content
Go to the home page of the European Commission (opens in new window)
English English
CORDIS - EU research results
CORDIS
Content archived on 2024-05-21

Modulation of the chemokine system in experimental models of disease

Objective

Chemokines constitute a super family of chemo tactic cytokines that play a role in directing the movements of leukocytes within the immune system. Exciting advances during the last year demonstrate a role for these molecules in the targeting of cells to inflammatory sites in a tissue specific manner, and also in tissue specific localisation of malignant cancer cells. So far investigations into chemokine pharmacology have almost exclusively been in vitro studies, and there is a definite need to acquire more biologically relevant information. The aim of this project is therefore to develop and characterise novel tools capable of interacting with the chemokine system, and to evaluate their utility in modulating chemokine signalling and subsequently the disease state.
There are two main project activities.
I. Protein engineering, expression and purification of specific chemokines and homologues.
II. Evaluation in relevant animal models of disease including arthritis, experimental autoimmune encephalitis, chemically induced delayed hypersensitivity and relevant gene knock out models. The chemokines offer a potential novel point of therapeutic intervention and the project will provide important understanding of the therapeutic value of chemokine related therapies in the clinical setting.

Topic(s)

Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.

Data not available

Call for proposal

Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.

Data not available

Funding Scheme

Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.

BUR - Bursaries, grants, fellowships

Coordinator

ACTIVE BIOTECH AB
EU contribution
No data
Address
Scheelevaegen 22
22007 LUND
Sweden

See on map

Total cost

The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.

No data
My booklet 0 0